The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans

Proceedings of the National Academy of Sciences of the United States of America

Volumn 100, Issue 8, 2003, Pages 4867-4872

  Mogil, Jeffrey S ^a,b   Wilson, Sonya G ^b   Chesler, Elissa J ^b   Rankin, Andrew L ^b   Nemmani, Kumar V S ^a   Lariviere, William R ^b   Groce, M Kristina ^c   Wallace, Margaret R ^d,e   Kaplan, Lee ^d   Staud, Roland ^e   Ness, Timothy J ^f   Glover, Toni L ^g   Stankova, Magda ^h   Mayorov, Alexander ^h   Hruby, Victor J ^h   Grisel, Judith E ^c   Fillingim, Roger B ^g  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c FURMAN UNIVERSITY   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^h University of Arizona   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; DIZOCILPINE; KAPPA OPIATE RECEPTOR; MELANOCORTIN 1 RECEPTOR; PENTAZOCINE; U 50 488;

ADULT; ALLELE; ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HAIR COLOR; HUMAN; MALE; MC1R GENE; MOUSE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR GENE; SKIN COLOR;

ADOLESCENT; ADULT; ALLELES; ANALGESIA; ANALGESICS, OPIOID; ANIMALS; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, MUTANT STRAINS; PAIN; PENTAZOCINE; RECEPTORS, CORTICOTROPIN; RECEPTORS, MELANOCORTIN; RECEPTORS, OPIOID, KAPPA; SEX CHARACTERISTICS; VARIATION (GENETICS);

ANIMALIA; RODENTIA;

EID: 0344341625     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0730053100     Document Type: Article

References (42)

1. Berkley, K. J. (1997) Behav. Brain Sci. 20, 371-380.
2. Liu, N.-J. & Gintzler, A. R. (2000) Pain 85, 273-281.
3. Tershner, S. A., Mitchell, J. M. & Fields, H. L. (2000) Pain 85, 153-159.
4. Mogil, J. S., Sternberg, W. F., Kest, B., Marek, P. & Liebeskind, J. C. (1993) Pain 53, 17-25.
5. Kavaliers, M. & Galea, L. A. M. (1995) Pain 63, 327-334.
6. Sternberg, W. F., Mogil, J. S., Pilati, M. L., Boun, C., Wong, S. K. & Liebeskind, J. C. (1994) Proc. West. Pharmacol. Soc. 37, 141-143.
7. Mogil, J. S., Richards, S. P., O'Toole, L. A., Helms, M. L., Mitchell, S. R., Kest, B. & Belknap, J. K. (1997) J. Neurosci. 17, 7995-8002.
8. Lander, E. S. & Schork, N. J. (1994) Science 265, 2037-2048.
9. Kavaliers, M. & Choleris, E. (1997) Brain Res. 768, 30-36.
10. Gear, R. W., Gordon, N. C., Heller, P. H., Paul, S. M., Miaskowski, C. & Levine, J. D. (1996) Neurosci. Lett. 205, 207-209.
11. Gear, R. W., Miaskowski, C., Gordon, N. C., Paul, S. M., Heller, P. H. & Levine, J. D. (1996) Nat. Med. 2, 1248-1250.
12. Gear, R. W., Miaskowski, C., Gordon, N. C., Paul, S. M., Heller, P. H. & Levine, J. D. (1999) Pain 83, 339-345.
13. Gear, R. W., Miaskowski, C., Gordon, N. C., Paul, S. M., Heller, P. H. & Levine, J. D. (2000) J. Pain 1, 122-127.
14. Tallarida, R. J. & Murray, R. B. (1981) Manual of Pharmacologic Calculation (Springer, New York).
15. Lander, E. S., Green, P., Abrahamson, J., Barlow, A., Daly, M. J., Lincoln, S. E. & Newburg, L. (1987) Genomics 1, 174-171.
16. Al-Obeidi, F., Hruby, V. J., Hadley, M. E., Sawyer, T. K. & Castrucci, A. M. (1990) Int. J. Pept. Protein Res. 35, 228-234.
17. Laursen, S. E. & Belknap, J. K. (1986) J. Pharmacol. Methods 16, 355-357.
18. Price, D. D., Hu, J. W., Dubner, R. & Gracely, R. H. (1977) Pain 3, 57-68.
19. Moore, P. A., Duncan, G. H., Scott, D. S., Gregg, J. M. & Ghia, J. N. (1979) Pain 6, 375-382.
20. Lander, E. S. & Kruglyak, L. (1995) Nat. Genet. 11, 241-247.
21. Cone, R. D., Lu, D., Koppula, S., Vage, D. I., Klungland, H., Boston, B., Chen, W., Orth, D. N., Pouton, C. & Kesterson, R. A. (1996) Rec. Prog. Horm. Res. 51, 287-317.
22. Tatro, J. B. (1996) Neuroimmunomodulation 3, 259-284.
23. Kolesnikov, Y., Jain, S., Wilson, R. & Pasternak, G. W. (1996) Eur. J. Pharmacol. 310, 141-143.
24. Han, G., Quillan, J. M., Carlson, K., Sadee, W. & Hruby, V. J. (2003) J. Med. Chem. 46, 810-819.
25. Sturm, R. A., Box, N. F. & Ramsay, M. (1998) BioEssays 20, 712-721.
26. Rees, J. L., Birch-Machin, M., Flanagan, N., Healy, E., Phillips, S. & Todd, C. (1999) Ann. N.Y. Acad. Sci. 885, 134-142.
27. Scott, M. C., Wakamatsu, K., Ito, S., Kadekaro, A. L., Kobayashi, N., Groden, J., Kavanagh, R., Takakuwa, T., Virador, V., Hearing, V. J. & Abdel-Malek, Z. A. (2002) J. Cell Sci. 115, 2349-2355.
28. Schioth, H. B., Phillips, S. R., Rudzish, R., Birch-Machin, M. A., Wikberg, J. E. S. & Rees, J. L. (1999) Biochem. Biophys. Res. Commun. 260, 488-491.
29. Healy, E., Jordan, S. A., Budd, P. S., Suffolk, R., Rees, J. L. & Jackson, I. J. (2001) Hum. Mol. Genet. 10, 2397-2402.
30. Nadeau, J. H. & Frankel, W. N. (2000) Nat. Genet. 25, 381-384.
31. Belknap, J. K., Hitzemann, R., Crabbe, J. C., Phillips, T. J., Buck, K. J. & Williams, R. W. (2001) Behav. Genet. 31, 5-15.
32. Korstanje, R. & Paigen, B. (2002) Nat. Genet. 31, 235-236.
33. Glazier, A. M., Nadeau, J. H. & Aitman, T. J. (2002) Science 298, 2345-2349.
34. Wikberg, J. E. S. (1999) Eur. J. Pharmacol. 375, 295-310.
35. Xia, Y., Wikberg, J. E. S. & Chhajlani, V. (1995) NeuroReport 6, 2193-2196.
36. Basbaum, A. I. & Fields, H. L. (1984) Annu. Rev. Neurosci. 7, 309-338.
37. Walker, J. M., Akil, H. & Watson, S. J. (1980) Science 210, 1247-1249.
38. Ohkubo, T., Shibata, M., Takahashi, H. & Naruse, S. (1985) Experientia 41, 627-628.
39. Gispen, W. H., Buitellar, J., Wiegant, V. M., Terenius, L. & De Wied, D. (1976) Eur. J. Pharmacol. 39, 393-397.
40. Manzanares, J., Wagner, E. J., Moore, K. E. & Lookingland, K. J. (1993) Life Sci. 53, 795-801.
41. Quillan, J. M. & Sadee, W. (1997) Pharmacol. Res. 14, 713-719.
42. Craft, R. M. (2003) Clin. J. Pain, in press.